Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer

Author:                

Publisher: Spandidos Publications

E-ISSN: 1791-3004|12|4|5771-5779

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.12, Iss.4, 2015-01, pp. : 5771-5779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract